DE69831684T2 - Verfahren zur Herstellung von hochvirusfreiem Thrombin zur Bereitung von Fibrinkleber aus menschlichem Plasma-Pool - Google Patents

Verfahren zur Herstellung von hochvirusfreiem Thrombin zur Bereitung von Fibrinkleber aus menschlichem Plasma-Pool Download PDF

Info

Publication number
DE69831684T2
DE69831684T2 DE69831684T DE69831684T DE69831684T2 DE 69831684 T2 DE69831684 T2 DE 69831684T2 DE 69831684 T DE69831684 T DE 69831684T DE 69831684 T DE69831684 T DE 69831684T DE 69831684 T2 DE69831684 T2 DE 69831684T2
Authority
DE
Germany
Prior art keywords
thrombin
solution
prothrombin
volume
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69831684T
Other languages
German (de)
English (en)
Other versions
DE69831684D1 (de
Inventor
Trung Bui-Khac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haemacure Corp Canada
Original Assignee
Haemacure Corp Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haemacure Corp Canada filed Critical Haemacure Corp Canada
Publication of DE69831684D1 publication Critical patent/DE69831684D1/de
Application granted granted Critical
Publication of DE69831684T2 publication Critical patent/DE69831684T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A61L2103/05—
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/92—Detection of biochemical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Materials For Medical Uses (AREA)
DE69831684T 1997-10-30 1998-10-29 Verfahren zur Herstellung von hochvirusfreiem Thrombin zur Bereitung von Fibrinkleber aus menschlichem Plasma-Pool Expired - Lifetime DE69831684T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/960,660 US5981254A (en) 1997-10-30 1997-10-30 Process for producing thrombin from plasma
US960660 1997-10-30
PCT/CA1998/001008 WO1999023111A1 (en) 1997-10-30 1998-10-29 Process for the production of highly viral safe components for forming fibrin glue from a pool of human plasma

Publications (2)

Publication Number Publication Date
DE69831684D1 DE69831684D1 (de) 2006-02-02
DE69831684T2 true DE69831684T2 (de) 2006-06-22

Family

ID=25503448

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69831684T Expired - Lifetime DE69831684T2 (de) 1997-10-30 1998-10-29 Verfahren zur Herstellung von hochvirusfreiem Thrombin zur Bereitung von Fibrinkleber aus menschlichem Plasma-Pool

Country Status (16)

Country Link
US (1) US5981254A (OSRAM)
EP (1) EP1027371B1 (OSRAM)
JP (1) JP4278861B2 (OSRAM)
AT (1) ATE305011T1 (OSRAM)
AU (1) AU759145B2 (OSRAM)
CA (1) CA2307380A1 (OSRAM)
DE (1) DE69831684T2 (OSRAM)
DK (1) DK1027371T3 (OSRAM)
ES (1) ES2249843T3 (OSRAM)
IL (1) IL135812A (OSRAM)
IN (1) IN185759B (OSRAM)
NO (1) NO323299B1 (OSRAM)
NZ (1) NZ504246A (OSRAM)
PL (1) PL194589B1 (OSRAM)
RU (1) RU2236237C2 (OSRAM)
WO (1) WO1999023111A1 (OSRAM)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
JP5080713B2 (ja) * 1999-12-20 2012-11-21 田辺三菱製薬株式会社 多孔性膜処理によるウイルスの除去された血漿蛋白組成物の製造方法、ウイルスの除去された血漿蛋白組成物およびウイルス除去方法
AU779126B2 (en) * 1999-12-23 2005-01-06 Csl Limited Separation of fibrinogen from plasma proteases
WO2001048016A1 (en) * 1999-12-23 2001-07-05 Csl Limited Separation of fibrinogen from plasma proteases
JP2002114799A (ja) * 2000-08-01 2002-04-16 Nihon Pharmaceutical Co Ltd ウイルス除去方法
US7411006B2 (en) 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US7365173B2 (en) * 2002-02-04 2008-04-29 American National Red Cross Method for the production of pure virally inactivated butyrylcholinesterase
DE10211632A1 (de) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
US20070015230A1 (en) * 2002-04-15 2007-01-18 Hammond David J Identification and characterization of analytes from whole blood
US20060275753A1 (en) * 2002-04-15 2006-12-07 Hammond David J Recovery of analytes using combinatorial libraries
US20060275829A1 (en) * 2002-04-15 2006-12-07 Hammond David J Combinatorial library for proteomic investigations
CN100525829C (zh) * 2002-04-15 2009-08-12 美国国家红十字会 检测混合物中配体和靶标的方法
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
DK1528930T3 (da) * 2002-07-23 2009-08-03 Bio & Bio Licensing Sa Thrombindannelsesdygtige og thrombinholdige farmaceutiske præparater af virksomt stof samt lægemidler
ES2214967B1 (es) * 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
ES2926359T3 (es) * 2003-12-01 2022-10-25 Novo Nordisk Healthcare Ag Filtración de virus de composiciones líquidas del Factor VII
WO2006009989A1 (en) * 2004-06-22 2006-01-26 Zymogenetics, Inc. Thrombin compositions
DE102004044429B4 (de) * 2004-09-14 2009-04-30 Biotest Ag Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor
ES2226587B1 (es) * 2004-10-22 2005-12-16 Probitas Pharma, S.A. Composicion de trombina estable.
US20060270015A1 (en) * 2005-05-26 2006-11-30 Dan Pawlak Thrombin purification
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US20120195953A1 (en) * 2007-09-19 2012-08-02 Kieu Hoang Fibrin sealant (FIBRINGLURAAS) consisting of a kit of lyophilized high concentrate fribinogen intentionally enriched and preserved with fibronolysis inhibitor A1AT
RU2369410C1 (ru) * 2008-05-06 2009-10-10 Александр Николаевич Данилин Способ очистки биологической жидкости организма (крови) от вирусной инфекции путем сорбции на магнитоуправляемых наночастицах и устройство для его осуществления
GB0814570D0 (en) * 2008-08-08 2008-09-17 Diagnostics For The Real World Isolation of nucleic acid
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
AU2013322604B2 (en) * 2012-09-26 2018-01-18 Bone Therapeutics S.A. Formulations involving solvent/detergent-treated plasma (S/D plasma) and uses thereof
RU2583931C2 (ru) * 2014-06-11 2016-05-10 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения концентрата тромбина
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
JP6666757B2 (ja) * 2016-03-10 2020-03-18 日本メジフィジックス株式会社 ポリオキシエチレン系非イオン界面活性剤の定量方法及び放射性医薬品製剤の製造方法
PE20210457A1 (es) * 2018-02-19 2021-03-08 Bayer Healthcare Llc Membrana de filtro modificada y metodo
WO2020229521A1 (en) 2019-05-14 2020-11-19 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for inhibiting or reducing bacterial biofilms on a surface
CN113754757B (zh) * 2021-07-01 2024-06-14 华兰生物工程股份有限公司 一种人纤维蛋白原的制备方法
WO2023020914A1 (en) 2021-08-18 2023-02-23 Biotest Ag Dry heat treatment of plasma-derived factor viii
KR20230121373A (ko) * 2022-02-11 2023-08-18 주식회사 녹십자 인자 xiii의 정제방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
RU2030183C1 (ru) * 1989-07-13 1995-03-10 Наталья Юрьевна Шатковская Состав для соединения биопластических материалов в отохирургии
RU2049470C1 (ru) * 1990-04-20 1995-12-10 Новокузнецкий институт усовершенствования врачей Способ получения альфа-макроглобулина
FR2679251B1 (fr) * 1991-07-18 1993-11-12 Nord Assoc Essor Transfusion San Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique.
US5290918A (en) * 1993-02-23 1994-03-01 Haemacure Biotech Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5506127A (en) * 1994-09-21 1996-04-09 Proba; Zbigniew Therapeutic grade thrombin produced by chromatography
RU2062103C1 (ru) * 1994-09-29 1996-06-20 Московская медицинская академия им.И.М.Сеченова Способ получения концентрата фибриногена

Also Published As

Publication number Publication date
JP2001521941A (ja) 2001-11-13
CA2307380A1 (en) 1999-05-14
US5981254A (en) 1999-11-09
AU759145B2 (en) 2003-04-03
PL340300A1 (en) 2001-01-29
EP1027371B1 (en) 2005-09-21
ES2249843T3 (es) 2006-04-01
DE69831684D1 (de) 2006-02-02
NO323299B1 (no) 2007-03-05
PL194589B1 (pl) 2007-06-29
RU2236237C2 (ru) 2004-09-20
AU9731698A (en) 1999-05-24
IL135812A (en) 2007-09-20
WO1999023111A1 (en) 1999-05-14
JP4278861B2 (ja) 2009-06-17
IN185759B (OSRAM) 2001-04-21
IL135812A0 (en) 2001-05-20
NO20002293D0 (no) 2000-04-28
NO20002293L (no) 2000-06-30
NZ504246A (en) 2002-09-27
ATE305011T1 (de) 2005-10-15
DK1027371T3 (da) 2006-01-09
EP1027371A1 (en) 2000-08-16

Similar Documents

Publication Publication Date Title
DE69831684T2 (de) Verfahren zur Herstellung von hochvirusfreiem Thrombin zur Bereitung von Fibrinkleber aus menschlichem Plasma-Pool
DE3033932C2 (de) Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
DE69027187T2 (de) Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
US5099003A (en) Method of preparing a sterile plasma-protein solution containing fibrinogen and factor xiii
DE3880292T2 (de) Ausscheidung von prozesschemikalien aus biologischen gemischen mit halogenierten kohlenwasserstoffen.
DE2801123C2 (de) Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
US4490361A (en) Virus inactivating heat treatment of plasma fractions
DE2231676A1 (de) Verfahren zur fraktionierung von blutserum und plasmaprodukten
EP0784632A1 (de) Verfahren zur gewinnung von hochreinem von willebrand-faktor
EP0674531A1 (de) Verfahren zur herstellung eines virussicheren biologischen präparates
DE3786832T2 (de) Verfahren zur Herstellung von Immunoglobulinzubereitungen für intravenöse Injektion.
EA003182B1 (ru) Универсальная плазма крови
EP0973544A1 (de) Immuntolerante prothrombinkomplex-präparation
AT391808B (de) Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
DE69627319T2 (de) Herstellung von immunglobulin
EP0011739B1 (en) Process for obtaining blood coagulation factor xiii derived from human placenta
DE69026513T2 (de) Polyhämoglobin durch purinderivate und glutathion stabilisiert
JP2008541731A (ja) トロンビンの精製
DE19623293C2 (de) Nicht-immunogene Faktor VIII-enthaltende Zusammensetzung und ein Verfahren zu ihrer Herstellung
AT406824B (de) Immuntolerante prothrombinkomplex-präparation
AT402151B (de) Verfahren zur herstellung eines virussicheren biologischen präparates
DE3324289A1 (de) Verfahren zur herstellung von sterilisierten humanen blutplasmaproteinen
de Lille llllllllllllllllllllllIlllllwglllllllllIllllllllllllllllllllllllllllllll
DE3537870A1 (de) Mit penicillamin behandelte injizierbare loesungen aus menschlichem vollblut und daraus gewonnene blutfraktionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition